HOME › DRUGS › ELVITEGRAVIR
ACTIVE SUBSTANCE / INN

ELVITEGRAVIR

Brand name(s): STRIBILD, GENVOYA, VITEKTA, Vitekta
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
DISCONTINUED
NDA203093
NDA207561
ACTIVE SUBSTANCE
Elvitegravir
REGULATORS
FDA · EMA
SPONSORS / MAH
GILEAD SCIENCES INC, Gilead Sciences International Ltd
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
GENVOYANDA207561GILEAD SCIENCES INCPrescription
VITEKTANDA203093GILEAD SCIENCES INCDiscontinued
STRIBILDNDA203100GILEAD SCIENCES INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VitektaGilead Sciences International LtdWithdrawn13/11/2013HIV Infections

FULL INTELLIGENCE ON ELVITEGRAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →